This project could lead to groundbreaking new clinical interventions for patients with neutropenia (an abnormally low level of neutrophils, a common type of white blood cell), antibiotic resistant infections, diabetes, autoimmune disease, cardiovascular disease, and cancer. It relies on the development of cutting-edge techniques for generating neutrophils and macrophages from induced pluripotent stem (iPS) cells […]
Read the full article at: https://research.wisc.edu/funding/uw2020/round-3-projects/engineering-leukocytes-generated-from-human-ips-cells-to-treat-human-disease/